Flublok Trivalent Northern Hemisphere 49281-0725-10
Generic: Influenza A Virus A/west Virginia/30/2022 (h1n1) Recombinant Hemagglutinin Antigen, Influenza A Virus A/district Of Columbia/27/2023 (h3n2) Recombinant Hemagglutinin Antigen, And Influenza B Virus B/austria/1359417/2021 Recombinant Hemagglutinin Antigen
- Manufacturer
- Sanofi Pasteur Inc.
- Dosage Form
- Injection
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- July 1, 2025
- Application
- BLA125285
Active Ingredients
| Ingredient | Strength |
|---|---|
| Influenza A Virus A/district Of Columbia/27/2023 (h3n2) Recombinant Hemagglutinin Antigen | 45 ug/.5mL |
| Influenza A Virus A/west Virginia/30/2022 (h1n1) Recombinant Hemagglutinin Antigen | 45 ug/.5mL |
| Influenza B Virus B/austria/1359417/2021 Recombinant Hemagglutinin Antigen | 45 ug/.5mL |
Selected Package
49281-0725-10Selected10 SYRINGE in 1 CARTON (49281-725-10) / .5 mL in 1 SYRINGE (49281-725-88)
External Resources